Skip to content
10-Q

Quarterly Report

NURIX THERAPEUTICS, INC. NRIX

0001549595-25-000113

← back to feed
Filed
Oct 9, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Sep 30, 2025 76.88M sh
Shares Diluted Q3 2025 · Aug 31, 2025 84.16M sh
Shares Diluted Q3 2025 · Aug 31, 2025 83.87M sh
Shares Diluted Q3 2025 · Aug 31, 2024 72.78M sh
Shares Diluted Q3 2025 · Aug 31, 2024 63.38M sh
Capex Q3 2025 · Aug 31, 2025 $8.87M
Capex Q3 2025 · Aug 31, 2024 $7.17M
Operating Cash Flow Q3 2025 · Aug 31, 2025 −$181.63M
Operating Cash Flow Q3 2025 · Aug 31, 2024 −$123.83M
Cash And Equivalents Q3 2025 · Aug 31, 2025 $78.44M
Cash And Equivalents Q3 2025 · Nov 30, 2024 $110M
Cash And Equivalents Q3 2025 · Aug 31, 2024 $99.04M
Stockholders Equity Q3 2025 · Aug 31, 2025 $372.25M
Stockholders Equity Q3 2025 · May 31, 2025 $447.6M
Stockholders Equity Q3 2025 · Feb 28, 2025 $480.92M
Stockholders Equity Q3 2025 · Nov 30, 2024 $526.99M
Stockholders Equity Q3 2025 · Aug 31, 2024 $376.86M
Stockholders Equity Q3 2025 · May 31, 2024 $370.69M
Stockholders Equity Q3 2025 · Feb 29, 2024 $168.75M
Stockholders Equity Q3 2025 · Nov 30, 2023 $200.49M
Current Liabilities Q3 2025 · Aug 31, 2025 $82.35M
Current Liabilities Q3 2025 · Nov 30, 2024 $95.85M
Total Liabilities Q3 2025 · Aug 31, 2025 $150.22M
Total Liabilities Q3 2025 · Nov 30, 2024 $142.35M
Current Assets Q3 2025 · Aug 31, 2025 $440.6M
Current Assets Q3 2025 · Nov 30, 2024 $619.39M
Total Assets Q3 2025 · Aug 31, 2025 $522.47M
Total Assets Q3 2025 · Nov 30, 2024 $669.34M
Eps Diluted Q3 2025 · Aug 31, 2025 −$1.03
Eps Diluted Q3 2025 · Aug 31, 2025 −$2.22
Eps Diluted Q3 2025 · Aug 31, 2024 −$0.67
Eps Diluted Q3 2025 · Aug 31, 2024 −$2.13
Eps Basic Q3 2025 · Aug 31, 2025 −$1.03
Eps Basic Q3 2025 · Aug 31, 2025 −$2.22
Eps Basic Q3 2025 · Aug 31, 2024 −$0.67
Eps Basic Q3 2025 · Aug 31, 2024 −$2.13
Sga Expense Q3 2025 · Aug 31, 2025 $13.16M
Sga Expense Q3 2025 · Aug 31, 2025 $39.1M
Sga Expense Q3 2025 · Aug 31, 2024 $11.72M
Sga Expense Q3 2025 · Aug 31, 2024 $35.23M
Rd Expense Q3 2025 · Aug 31, 2025 $86.12M
Rd Expense Q3 2025 · Aug 31, 2025 $233.88M
Rd Expense Q3 2025 · Aug 31, 2024 $55.48M
Rd Expense Q3 2025 · Aug 31, 2024 $154.41M
Net Income Q3 2025 · Aug 31, 2025 −$86.42M
Net Income Q3 2025 · Aug 31, 2025 −$186.24M
Net Income Q3 2025 · May 31, 2025 −$43.46M
Net Income Q3 2025 · Feb 28, 2025 −$56.35M
Net Income Q3 2025 · Aug 31, 2024 −$48.96M
Net Income Q3 2025 · Aug 31, 2024 −$135.02M
Net Income Q3 2025 · May 31, 2024 −$44.55M
Net Income Q3 2025 · Feb 29, 2024 −$41.52M
Operating Income Q3 2025 · Aug 31, 2025 −$91.39M
Operating Income Q3 2025 · Aug 31, 2025 −$202.57M
Operating Income Q3 2025 · Aug 31, 2024 −$54.61M
Operating Income Q3 2025 · Aug 31, 2024 −$148.37M
Revenue Q3 2025 · Aug 31, 2025 $7.89M
Revenue Q3 2025 · Aug 31, 2025 $70.4M
Revenue Q3 2025 · Aug 31, 2024 $12.59M
Revenue Q3 2025 · Aug 31, 2024 $41.27M